Can Fite Biopharma Stock Price on April 25, 2024

CANF Stock  USD 2.10  0.05  2.44%   
Below is the normalized historical share price chart for Can Fite Biopharma extending back to November 01, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Can Fite stands at 2.10, as last reported on the 28th of November, with the highest price reaching 2.25 and the lowest price hitting 2.07 during the day.
IPO Date
6th of November 2012
200 Day MA
2.4059
50 Day MA
2.212
Beta
0.567
 
Yuan Drop
 
Covid
If you're considering investing in Can Stock, it is important to understand the factors that can impact its price. Can Fite Biopharma secures Sharpe Ratio (or Efficiency) of -0.0019, which signifies that the company had a -0.0019% return per unit of risk over the last 3 months. Can Fite Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Can Fite's insignificant Risk Adjusted Performance, standard deviation of 4.0, and Mean Deviation of 2.77 to double-check the risk estimate we provide.
  
At this time, Can Fite's Common Stock is most likely to increase significantly in the upcoming years. The Can Fite's current Stock Based Compensation is estimated to increase to about 350.5 K, while Total Stockholder Equity is projected to decrease to roughly 5.6 M. . The Can Fite's current Price Earnings To Growth Ratio is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 12.14. Can Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0019

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCANF

Estimated Market Risk

 4.05
  actual daily
36
64% of assets are more volatile

Expected Return

 -0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average Can Fite is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Can Fite by adding Can Fite to a well-diversified portfolio.
Price Book
5.0414
Enterprise Value Ebitda
0.0965
Price Sales
20.0458
Shares Float
1.7 B
Wall Street Target Price
13.3333

Can Fite Valuation on April 25, 2024

It is possible to determine the worth of Can Fite on a given historical date. On April 25, 2024 Can was worth 1.94 at the beginning of the trading date compared to the closed value of 1.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Can Fite stock. Still, in general, we apply an absolute valuation method to find Can Fite's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Can Fite where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Can Fite's related companies.
 Open High Low Close Volume
  1.96    1.96    1.93    1.94    5,741  
04/25/2024
  1.94    1.97    1.91    1.92    12,346  
  2.00    2.01    1.91    1.98    8,665  
Backtest Can Fite  |  Can Fite History  |  Can Fite Valuation   PreviousNext  
Open Value
1.94
1.92
Closing Value
14.09
Upside

Can Fite Trading Date Momentum on April 25, 2024

On April 26 2024 Can Fite Biopharma was traded for  1.98  at the closing time. The top price for the day was 2.01  and the lowest listed price was  1.91 . The trading volume for the day was 8.7 K. The trading history from April 26, 2024 was a factor to the next trading day price rise. The overall trading delta against the next closing price was 3.13% . The overall trading delta against the current closing price is 20.83% .

Can Fite Biopharma Fundamentals Correlations and Trends

By evaluating Can Fite's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Can Fite's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Can financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Can Fite Stock history

Can Fite investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Can is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Can Fite Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Can Fite stock prices may prove useful in developing a viable investing in Can Fite
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.3 MM
Net Loss-11.7 M-12.3 M

Can Fite Quarterly Net Working Capital

7.89 Million

Can Fite Stock Technical Analysis

Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Can Fite technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Can Fite trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Can Fite Period Price Range

Low
November 28, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Can Fite Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Can Fite November 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Can Fite stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Can Fite shares will generate the highest return on investment. By undertsting and applying Can Fite stock market strength indicators, traders can identify Can Fite Biopharma entry and exit signals to maximize returns

Can Fite Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Can Fite's price direction in advance. Along with the technical and fundamental analysis of Can Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Can to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Can Stock analysis

When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios